Centro Hospitalar de Lisboa Ocidental, EPE
Automated case report generated from contract-level risk evidence.
Executive Highlights
3 companies receive 34.4% of total spend
8,949 of 12,617 contracts (70.9%) have active risk signals
Supplier concentration is low (HHI 0.0879)
800 individuals (aggregate count) linked to 102 winner companies
62 individuals are linked to multiple winner companies
Person-company link evidence is available for 102 of 1,082 winner companies (9.4%); 980 have no link data
Award timing distribution is within expected bounds: 34% in Mar/Jun/Sep/Dec; 8.7% in December
Key Metrics
| Company | Awarded value | Share |
|---|---|---|
| MERCK, S.A. | €11,055,086,240 | 27.9% |
| JANSSEN - CILAG FARMACÊUTICA LDA | €1,371,811,758 | 3.5% |
| NOVARTIS FARMA - PRODUTOS FARMACÊUTICOS S.A. | €1,200,736,458 | 3% |
Network Cluster Map
Main cluster focused on this entity with person-company links.
Whole Procurement Map
Global contract links across public bodies and companies
Public mode hides individual nodes and shows only connected-individual totals.
Navigate: drag to pan, use mouse wheel to zoom, and reset view when needed.
Top 30 High-Risk Contracts
Highest combined risk score, with indicator evidence.
| Contract | Date | Value | Risk | Evidence |
|---|---|---|---|---|
|
AQUISIÇÃO DE SERVIÇOS DE LIMPEZA COM FORNECIMENTO DE CONSUMÍVEIS NAS UNIDADES DE SAÚDE DE LISBOA OCIDENTAL E OEIRAS NO PRAZO MÁXIMO DE 2 MESES
10902527
|
2024-08-22 | €149,510 | 145 (4) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=1171
A2 · Late Publication
(40)
publication_date=2024-09-04 | celebration_date=2024-08-22
A5 · Threshold Splitting
(35)
base_price=149510.0 | threshold=150000.0
|
|
111025625- Aquisição de Gentamicina 130 Mg IMPL SAQ INTRALESIONAL-2025
12143783
|
2025-04-16 | €4,900 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=524
A2 · Late Publication
(40)
publication_date=2025-12-18 | celebration_date=2025-04-16
A5 · Threshold Splitting
(35)
base_price=4900.0 | threshold=5000.0
|
|
AQUISICAO DO MEDICAMENTO TRALOCINUMAB 150 MG/1 ML SOL INJ SER 1 ML SC - 2023
10573073
|
2023-12-05 | €4,990 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=492
A2 · Late Publication
(40)
publication_date=2024-02-21 | celebration_date=2023-12-05
A5 · Threshold Splitting
(35)
base_price=4990.0 | threshold=5000.0
|
|
PESQUISA DE ANTIGENIOS
10529422
|
2023-02-22 | €19,822 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=514
A2 · Late Publication
(40)
publication_date=2024-01-30 | celebration_date=2023-02-22
A5 · Threshold Splitting
(35)
base_price=19822.0 | threshold=20000.0
|
|
Manutenção do sistema de backup Veeam para gestão de cópias de segurança para o ano de 2023
10256067
|
2023-01-09 | €19,026 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=2775
A2 · Late Publication
(40)
publication_date=2023-09-22 | celebration_date=2023-01-09
A5 · Threshold Splitting
(35)
base_price=19026.0 | threshold=20000.0
|
|
11802930 - CACIFOS VESTIARIOS PARA O S. HIGIENE E LIMPEZA DO HSC
9864844
|
2020-06-12 | €19,375 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=5389
A2 · Late Publication
(40)
publication_date=2023-03-15 | celebration_date=2020-06-12
A5 · Threshold Splitting
(35)
base_price=19375.0 | threshold=20000.0
|
|
11800351 - Ventilador UTAN
9830236
|
2021-01-18 | €4,982 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=6624
A2 · Late Publication
(40)
publication_date=2023-03-01 | celebration_date=2021-01-18
A5 · Threshold Splitting
(35)
base_price=4982.0 | threshold=5000.0
|
|
Reagentes para Pesquisa de SARS-CoV-2
7365466
|
2020-03-16 | €74,200 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=237
A2 · Late Publication
(40)
publication_date=2020-12-31 | celebration_date=2020-03-16
A5 · Threshold Splitting
(35)
base_price=74200.0 | threshold=75000.0
|
|
AD801907 - Aquisição de Camaras Frigoríficas para Cadáveres do CHLO, EPE (HEM)
3901973
|
2017-10-26 | €71,710 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=515
A2 · Late Publication
(40)
publication_date=2017-11-16 | celebration_date=2017-10-26
A5 · Threshold Splitting
(35)
base_price=72500.0 | threshold=75000.0
|
|
Aquisição de serviços médicos para a Urgência Geral, durante o mês de julho de 2016
2992923
|
2016-07-01 | €19,000 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=5538
A2 · Late Publication
(40)
publication_date=2017-02-07 | celebration_date=2016-07-01
A5 · Threshold Splitting
(35)
base_price=19000.0 | threshold=20000.0
|
|
AD802175 - ARMÁRIOS - CIRURGIA GERAL DO HSFX
1906712
|
2015-09-30 | €11,078 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=402
A2 · Late Publication
(40)
publication_date=2015-12-18 | celebration_date=2015-09-30
A5 · Threshold Splitting
(35)
base_price=19000.0 | threshold=20000.0
|
|
Fornecimento de Material de Electromedicina durante o ano de 2014 para o CHLO
1576947
|
2014-09-29 | €51,172 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=94
A2 · Late Publication
(40)
publication_date=2015-09-18 | celebration_date=2014-09-29
A5 · Threshold Splitting
(35)
base_price=74557.0 | threshold=75000.0
|
|
AD704654 - Aquisição de Serviços de Alimentação para o CHLO no mês de Abril de 2014
1055084
|
2014-04-04 | €143,160 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=1608
A2 · Late Publication
(40)
publication_date=2014-05-07 | celebration_date=2014-04-04
A5 · Threshold Splitting
(35)
base_price=148000.0 | threshold=150000.0
|
|
AD703184 - Aquisição de Prestação de Serviços de Alimentação para o CHLO no mês de Março de 2014
1012482
|
2014-03-05 | €143,160 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=1608
A2 · Late Publication
(40)
publication_date=2014-03-20 | celebration_date=2014-03-05
A5 · Threshold Splitting
(35)
base_price=148000.0 | threshold=150000.0
|
|
AQUISIÇÃO DE SERVIÇOS DE ALIMENTAÇÃO PARA O CHLO NO MÊS DE JANEIRO 2014
962073
|
2014-01-08 | €143,160 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=1608
A2 · Late Publication
(40)
publication_date=2014-01-27 | celebration_date=2014-01-08
A5 · Threshold Splitting
(35)
base_price=148000.0 | threshold=150000.0
|
|
Aquisição de Clemastina 2 Mg/2ml à Empresa Inovemed para 2024
10637709
|
2024-03-01 | €6,795 | 120 (4) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=426
A2 · Late Publication
(40)
publication_date=2024-03-26 | celebration_date=2024-03-01
A6 · Low Competition
(20)
rule=a6_single_bidder | bidder_count=1
|
|
167000525 – Aquisição de serviços médicos durante o ano de 2025 na VMER da ULSLO, EPE
11587007
|
2025-06-05 | €15,898 | 110 (4) |
A2 · Late Publication
(40)
publication_date=2025-07-16 | celebration_date=2025-06-05
A5 · Threshold Splitting
(35)
base_price=145000.0 | threshold=150000.0
C1 · Missing Supplier NIF
(25)
rule=C1 no winner recorded: awarded contract (effective price > 0) has no supplier identified
|
|
167000525 – Aquisição de serviços médicos durante o ano de 2025 na VMER da ULSLO, EPE
11586680
|
2025-01-13 | €28,782 | 110 (4) |
A2 · Late Publication
(40)
publication_date=2025-07-16 | celebration_date=2025-01-13
A5 · Threshold Splitting
(35)
base_price=145000.0 | threshold=150000.0
C1 · Missing Supplier NIF
(25)
rule=C1 no winner recorded: awarded contract (effective price > 0) has no supplier identified
|
|
167000525 – Aquisição de serviços médicos durante o ano de 2025 na VMER da ULSLO, EPE
11586979
|
2025-01-03 | €28,782 | 110 (4) |
A2 · Late Publication
(40)
publication_date=2025-07-16 | celebration_date=2025-01-03
A5 · Threshold Splitting
(35)
base_price=145000.0 | threshold=150000.0
C1 · Missing Supplier NIF
(25)
rule=C1 no winner recorded: awarded contract (effective price > 0) has no supplier identified
|
|
Aquisição Exclusiva RISPERIDONA LRovi 2024
10950744
|
2024-08-22 | €24,076 | 110 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=253
A2 · Late Publication
(40)
publication_date=2024-10-04 | celebration_date=2024-08-22
A6 · Low Competition
(20)
rule=a6_single_bidder | bidder_count=1
|
|
Manutenção preventiva assistência técnica a 4 Monitores de Diálise e 3 WRO em 2024, 2025 e 2026
10946285
|
2024-08-25 | €76,200 | 110 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=1371
A2 · Late Publication
(40)
publication_date=2024-10-01 | celebration_date=2024-08-25
A6 · Low Competition
(20)
rule=a6_single_bidder | bidder_count=1
|
|
Aquisição de Detergente de Superficie Anodizada para a ULSLO, EPE
10927996
|
2024-04-24 | €100 | 110 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=609
A2 · Late Publication
(40)
publication_date=2024-09-19 | celebration_date=2024-04-24
A6 · Low Competition
(20)
rule=a6_single_bidder | bidder_count=1
|
|
Aquisição de Formulas para Prematuros PDF e em Monodode para a ULSLO, EPE
10925880
|
2024-08-14 | €803 | 110 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=325
A2 · Late Publication
(40)
publication_date=2024-09-18 | celebration_date=2024-08-14
A6 · Low Competition
(20)
rule=a6_single_bidder | bidder_count=1
|
|
Aquisição de Indicador c/ Tabela Referência Exposição UVD para ULSLO, EPE
10922361
|
2024-08-13 | €1,325 | 110 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=489
A2 · Late Publication
(40)
publication_date=2024-09-17 | celebration_date=2024-08-13
A6 · Low Competition
(20)
rule=a6_single_bidder | bidder_count=1
|
|
AQUISIÇÃO DE REAGENTES PARA PESQUISA CLOSTRIDIUM, E.COLI, ENTAMOEBA E GIARDIA
10795676
|
2024-04-07 | €24,472 | 110 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=514
A2 · Late Publication
(40)
publication_date=2024-06-29 | celebration_date=2024-04-07
A6 · Low Competition
(20)
rule=a6_single_bidder | bidder_count=1
|
|
Aquisição de Medicamentos AUE à Empresa Dux Pharma-2024
10728584
|
2024-01-24 | €20,520 | 110 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=265
A2 · Late Publication
(40)
publication_date=2024-05-21 | celebration_date=2024-01-24
A6 · Low Competition
(20)
rule=a6_single_bidder | bidder_count=1
|
|
AQUISIÇÃODE CLORETO DE ACETILCOLINA 20 MG PO SOL INJ FR IOCULAR - 2024 -
10660091
|
2024-02-20 | €511 | 110 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=426
A2 · Late Publication
(40)
publication_date=2024-04-10 | celebration_date=2024-02-20
A6 · Low Competition
(20)
rule=a6_single_bidder | bidder_count=1
|
|
Aquisição de medicamentos AUES à empresa INOVEMED - Produtos Farmacêuticos LDA
10659381
|
2024-01-11 | €1,899 | 110 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=52007
A2 · Late Publication
(40)
publication_date=2024-04-10 | celebration_date=2024-01-11
A6 · Low Competition
(20)
rule=a6_single_bidder | bidder_count=1
|
|
Aquisicao de Gases ACAIL GAS, S.A. UI para ULSLO - 2024
10659754
|
2024-02-27 | €59,847 | 110 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=339
A2 · Late Publication
(40)
publication_date=2024-04-10 | celebration_date=2024-02-27
A6 · Low Competition
(20)
rule=a6_single_bidder | bidder_count=1
|
|
Aquisição de Medicamentos AUE à Empresa X Pharma para 2024
10659548
|
2024-02-07 | €6,452 | 110 (3) |
A1 · Repeat Direct Award
(50)
authority_id=50 | supplier_id=516
A2 · Late Publication
(40)
publication_date=2024-04-10 | celebration_date=2024-02-07
A6 · Low Competition
(20)
rule=a6_single_bidder | bidder_count=1
|
Award Timeline
Monthly award volume and amendment risk signals.
| Period | Awards | Awarded value | Amendment signals |
|---|---|---|---|
| 2012-01 | 1 | €1,507,020 | 0 |
| 2012-03 | 1 | €786,232 | 0 |
| 2012-04 | 2 | €128,900 | 0 |
| 2012-09 | 3 | €259,940 | 0 |
| 2012-10 | 7 | €218,473 | 0 |
| 2012-11 | 7 | €1,601,271 | 0 |
| 2012-12 | 9 | €760,260 | 0 |
| 2013-01 | 25 | €1,977,913 | 0 |
| 2013-02 | 25 | €756,893 | 0 |
| 2013-03 | 15 | €3,702,697 | 0 |
| 2013-04 | 13 | €1,025,492 | 0 |
| 2013-05 | 14 | €572,884 | 0 |
| 2013-06 | 7 | €970,051 | 0 |
| 2013-07 | 12 | €609,892 | 0 |
| 2013-08 | 5 | €177,317 | 0 |
| 2013-09 | 3 | €693,482 | 0 |
| 2013-10 | 3 | €32,624 | 0 |
| 2013-11 | 10 | €1,428,784 | 0 |
| 2013-12 | 13 | €3,328,730 | 0 |
| 2014-01 | 40 | €3,657,160 | 0 |
| 2014-02 | 32 | €1,946,674 | 0 |
| 2014-03 | 36 | €3,185,952 | 0 |
| 2014-04 | 23 | €3,652,906 | 0 |
| 2014-05 | 16 | €2,979,744 | 0 |
| 2014-06 | 9 | €1,045,120 | 0 |
| 2014-07 | 31 | €1,899,100 | 0 |
| 2014-08 | 1 | €140,000 | 0 |
| 2014-09 | 16 | €482,545 | 0 |
| 2014-10 | 13 | €3,045,582 | 0 |
| 2014-11 | 11 | €217,427 | 0 |
| 2014-12 | 15 | €2,526,420 | 0 |
| 2015-01 | 25 | €3,542,250 | 0 |
| 2015-02 | 56 | €2,993,197 | 0 |
| 2015-03 | 18 | €693,323 | 0 |
| 2015-04 | 22 | €3,968,234 | 0 |
| 2015-05 | 13 | €314,020 | 0 |
| 2015-06 | 45 | €6,046,402 | 0 |
| 2015-07 | 28 | €9,220,009 | 0 |
| 2015-08 | 26 | €5,180,429 | 0 |
| 2015-09 | 30 | €5,296,715 | 0 |
| 2015-10 | 27 | €1,764,544 | 0 |
| 2015-11 | 14 | €3,299,323 | 0 |
| 2015-12 | 15 | €2,275,391 | 0 |
| 2016-01 | 48 | €5,822,532 | 0 |
| 2016-02 | 40 | €8,998,950 | 0 |
| 2016-03 | 57 | €10,904,057 | 0 |
| 2016-04 | 36 | €10,267,368 | 0 |
| 2016-05 | 36 | €2,527,499 | 0 |
| 2016-06 | 27 | €2,572,437 | 0 |
| 2016-07 | 25 | €3,753,901 | 0 |
| 2016-08 | 30 | €3,613,379 | 0 |
| 2016-09 | 46 | €1,563,911 | 0 |
| 2016-10 | 41 | €2,204,237 | 0 |
| 2016-11 | 10 | €461,293 | 0 |
| 2016-12 | 32 | €2,557,059 | 0 |
| 2017-01 | 23 | €2,434,394 | 0 |
| 2017-02 | 12 | €1,430,805 | 0 |
| 2017-03 | 37 | €3,264,093 | 0 |
| 2017-04 | 36 | €3,581,618 | 0 |
| 2017-05 | 60 | €10,718,668 | 0 |
| 2017-06 | 31 | €4,913,485 | 0 |
| 2017-07 | 48 | €7,244,878 | 0 |
| 2017-08 | 39 | €2,370,569 | 0 |
| 2017-09 | 38 | €4,664,090 | 0 |
| 2017-10 | 29 | €1,498,509 | 0 |
| 2017-11 | 49 | €11,073,414 | 0 |
| 2017-12 | 58 | €8,612,327 | 0 |
| 2018-01 | 37 | €2,663,009 | 0 |
| 2018-02 | 22 | €1,873,738 | 0 |
| 2018-03 | 44 | €2,849,469 | 0 |
| 2018-04 | 41 | €4,999,130 | 0 |
| 2018-05 | 43 | €1,878,112 | 0 |
| 2018-06 | 45 | €1,649,801 | 0 |
| 2018-07 | 46 | €4,575,382 | 0 |
| 2018-08 | 47 | €4,403,199 | 0 |
| 2018-09 | 33 | €1,475,266 | 0 |
| 2018-10 | 56 | €2,967,971 | 0 |
| 2018-11 | 34 | €1,383,192 | 0 |
| 2018-12 | 48 | €3,160,970 | 0 |
| 2019-01 | 106 | €23,174,678 | 0 |
| 2019-02 | 55 | €4,992,037 | 0 |
| 2019-03 | 68 | €5,465,620 | 0 |
| 2019-04 | 65 | €2,668,351 | 0 |
| 2019-05 | 64 | €2,355,534 | 0 |
| 2019-06 | 46 | €6,684,708 | 0 |
| 2019-07 | 58 | €5,479,851 | 0 |
| 2019-08 | 45 | €1,192,956 | 0 |
| 2019-09 | 35 | €1,939,675 | 0 |
| 2019-10 | 33 | €4,758,787 | 0 |
| 2019-11 | 47 | €1,032,495 | 0 |
| 2019-12 | 108 | €17,670,607 | 0 |
| 2020-01 | 93 | €10,056,251 | 0 |
| 2020-02 | 63 | €7,256,176 | 0 |
| 2020-03 | 92 | €8,637,363 | 0 |
| 2020-04 | 84 | €3,825,788 | 0 |
| 2020-05 | 268 | €4,499,976 | 0 |
| 2020-06 | 303 | €6,505,870 | 0 |
| 2020-07 | 269 | €5,885,322 | 0 |
| 2020-08 | 103 | €2,036,995 | 0 |
| 2020-09 | 134 | €4,219,373 | 0 |
| 2020-10 | 159 | €6,195,573 | 0 |
| 2020-11 | 169 | €6,846,633 | 0 |
| 2020-12 | 234 | €11,043,756 | 0 |
| 2021-01 | 160 | €6,579,698 | 0 |
| 2021-02 | 289 | €33,502,161 | 0 |
| 2021-03 | 267 | €19,459,845 | 0 |
| 2021-04 | 137 | €8,292,359 | 0 |
| 2021-05 | 156 | €2,587,950 | 0 |
| 2021-06 | 112 | €6,237,646 | 0 |
| 2021-07 | 97 | €6,671,410 | 0 |
| 2021-08 | 50 | €1,890,821 | 0 |
| 2021-09 | 41 | €1,413,082 | 0 |
| 2021-10 | 73 | €3,478,088 | 0 |
| 2021-11 | 55 | €1,710,670 | 0 |
| 2021-12 | 121 | €1,710,864 | 0 |
| 2022-01 | 132 | €7,103,693 | 0 |
| 2022-02 | 135 | €31,567,387 | 0 |
| 2022-03 | 126 | €15,553,970 | 0 |
| 2022-04 | 117 | €15,531,146 | 0 |
| 2022-05 | 85 | €2,984,518 | 0 |
| 2022-06 | 123 | €10,510,370 | 0 |
| 2022-07 | 69 | €9,838,126 | 0 |
| 2022-08 | 94 | €6,674,910 | 0 |
| 2022-09 | 115 | €2,787,325 | 0 |
| 2022-10 | 41 | €2,950,645 | 0 |
| 2022-11 | 69 | €4,128,425 | 0 |
| 2022-12 | 56 | €2,091,919 | 0 |
| 2023-01 | 104 | €17,583,104 | 0 |
| 2023-02 | 72 | €17,361,144 | 0 |
| 2023-03 | 120 | €24,459,456 | 0 |
| 2023-04 | 154 | €29,633,061 | 0 |
| 2023-05 | 87 | €11,325,477 | 0 |
| 2023-06 | 93 | €6,145,478 | 0 |
| 2023-07 | 101 | €10,909,304 | 0 |
| 2023-08 | 73 | €4,247,682 | 0 |
| 2023-09 | 80 | €10,670,469 | 0 |
| 2023-10 | 124 | €10,875,458 | 0 |
| 2023-11 | 145 | €6,021,398 | 0 |
| 2023-12 | 137 | €13,510,826 | 0 |
| 2024-01 | 182 | €43,403,713 | 0 |
| 2024-02 | 157 | €27,513,210 | 0 |
| 2024-03 | 168 | €38,900,685 | 0 |
| 2024-04 | 175 | €7,967,945 | 0 |
| 2024-05 | 155 | €10,740,090 | 0 |
| 2024-06 | 100 | €13,298,847 | 0 |
| 2024-07 | 117 | €12,142,391 | 0 |
| 2024-08 | 113 | €9,974,836 | 0 |
| 2024-09 | 113 | €11,470,637 | 0 |
| 2024-10 | 105 | €7,417,628 | 0 |
| 2024-11 | 63 | €2,842,133 | 0 |
| 2024-12 | 137 | €18,774,379 | 0 |
| 2025-01 | 340 | €27,686,043 | 0 |
| 2025-02 | 138 | €13,151,093 | 0 |
| 2025-03 | 279 | €65,489,134 | 0 |
| 2025-04 | 186 | €18,948,179 | 0 |
| 2025-05 | 129 | €12,971,514 | 0 |
| 2025-06 | 95 | €11,968,903 | 0 |
| 2025-07 | 182 | €16,883,942 | 0 |
| 2025-08 | 163 | €18,172,694 | 0 |
| 2025-09 | 137 | €14,509,337 | 0 |
| 2025-10 | 121 | €6,739,112 | 0 |
| 2025-11 | 143 | €12,720,715 | 0 |
| 2025-12 | 114 | €5,050,230 | 0 |
| 2026-01 | 90 | €11,297,645 | 0 |
| 2026-02 | 83 | €2,569,342 | 0 |
Risk scoring combines rule-based indicators with data quality flags. Values and confidence degrade when critical fields are missing.